Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Ajinomoto Bio-Pharma Services Successfully Develops Highly Functional Ancestral RNA Ligase 2023-02-22 21:05
Ajinomoto and Exelixis Enter Into a License Agreement to Discover and Develop Novel Antibody-Drug Conjugates for the Treatment of Cancer 2023-01-10 21:05
Ajinomoto and XL-protein Forge Strategic Alliance to Develop PASylated Therapeutics Applying the Corynex® Platform 2018-12-18 23:00
1